Skip to content

Effects of liposomal bupivacaine combined with weak opioid-based anesthesia management on short-term postoperative prognosis and tumor recurrence in breast cancer patients

Effects of liposomal bupivacaine combined with weak opioid-based anesthesia management on short-term postoperative prognosis and tumor recurrence in breast cancer patients

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600124414
Enrollment
Unknown
Registered
2026-05-12
Start date
2026-05-15
Completion date
Unknown
Last updated
2026-05-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast cancer

Interventions

Experimental group:Preoperative and postoperative nerve block with liposomal bupivacaine in patients undergoing breast cancer surgery.
Control group:Routine preoperative and postoperative analgesia in patients undergoing breast cancer surgery.

Sponsors

The First Affiliated Hospital of University of Science and Technology of China
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Confirmed breast cancer patients aged <=80 years. 2. Patients with preoperative American Society of Anesthesiologists (ASA) physical status classification I–III. 3. No evidence of metastasis to organs or tissues beyond the breast, with or without ipsilateral local lymph node metastasis (i.e., T1–4, N0–1, M0). 4. Undergoing unilateral mastectomy, with or without lymph node dissection.

Exclusion criteria

Exclusion criteria: 1. Patients with a previous history of malignant tumors or prior surgery for malignancy. 2. Patients with a prior history of severe cardiovascular or cerebrovascular events, such as myocardial infarction or cerebrovascular accident (stroke), with significant sequelae. 3. Patients with a previous history of allergy to bupivacaine.

Design outcomes

Primary

MeasureTime frame
Incidence of perioperative pain;

Secondary

MeasureTime frame
Anesthesia recovery status;Incidence of chronic postoperative pain;Postoperative local or metastatic recurrence of breast cancer;Intraoperative hemodynamic changes;

Countries

China

Contacts

Public ContactXie Yanhu

The First Affiliated Hospital of University of Science and Technology of China

xyh200701@sina.cn+86 181 6088 6165

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 22, 2026